映恩生物-B:股份将调入恒生综合指数成份股及港股通

格隆汇
Sep 07

映恩生物-B公告,自2025年9月8日起,公司股份将获恒生指数有限公司纳入恒生综合指数成份股,并被调入沪港通下港股通标的名单。此举代表资本市场对公司表现及价值的高度认同,预计将扩大投资者基础并增加股份交易流通量。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10